Know Cancer

or
forgot password

Natural Orifice Translumenal Endoscopic Surgery (NOTES) Cystgastrostomy for the Treatment of Pancreatic Pseudocysts


N/A
18 Years
90 Years
Open (Enrolling)
Both
Pancreatic Pseudocyst

Thank you

Trial Information

Natural Orifice Translumenal Endoscopic Surgery (NOTES) Cystgastrostomy for the Treatment of Pancreatic Pseudocysts


Introduction: Natural Orifice Translumenal Endoscopic Surgery (NOTES) describes a new field
of investigational surgery which uses the endoscope as the primary operative tool.
Multiple animal studies utilizing similar techniques are ongoing at several institutions,
including Baystate Medical Center. These multidisciplinary teams consist of surgeons and
gastroenterologists who are collaborating to develop safe and effective surgical techniques
via the natural orifice route in order to avoid surgical incisions.

Pancreatic pseudocysts are cavities that form typically in the lesser sac following an
episode of acute pancreatitis. These pseudocysts may become infected, and may have
detrimental outcomes caused by their mass effect on the stomach and/or small intestine.
Pseudocysts are able to be drained by a variety of techniques, including endoscopically.
Chronic pseudocysts often require surgical drainage into the stomach or jejunum as they may
contain solid material that does not drain. Typically, cystgastrostomies or
cystenterotomies are performed utilizing an abdominal incision with subsequent suturing or
stapling.

The medical device company known as "Power Medical Interventions" has a computer-powered
surgical stapler which rests on a flexible shaft. There has been subsequent development of
a linear version of this stapler which was designed for gastrointestinal anastomosis which
will be utilized in this research project known as a "powered stapler".

An endoscope would be inserted in the mouth, and down into the stomach after the induction
of general anesthesia. Following the insertion of the endoscope, the powered stapler will
be passed alongside the endoscope to help the surgeon and gastroenterologist (working as a
team) to see where to properly place the stapler. If a connection has been previously made
between the stomach and pseudocyst, the stapler will be maneuvered into the proper position.
If a connection has not yet been made, this will be done during the procedure with the aid
of an endoscopic ultrasound probe passed through the mouth. Once the stapler is in
position, one jaw of the stapler will be placed into the pseudocyst, and the other jaw will
be left in the stomach. The stapler will then be closed and fired, creating a permanent
connection between the two hollow spaces and allow the contents of the pseudocyst to drain
naturally out into the stomach and intestines. The stapler and the endoscope are then
removed and the anesthesia is allowed to wear off. Utilizing this technique, a surgical
incision is avoided.

Primary Objective: The primary objective of this study is to demonstrate that the Natural
Orifice Translumenal Endoscopic Surgery (NOTES) technique is as effective as standard
surgical technique for the permanent drainage of pancreatic pseudocysts.

Secondary Objective: The secondary objective of this research project is to demonstrate a
decreased degree of pain experienced by patients undergoing the Natural Orifice Translumenal
Endoscopic Surgery versus traditional methods.

Hypothesis: Patients who undergo the Natural Orifice Translumenal Endoscopic Surgery for
treatment of their pancreatic pseudocyst will experience effective treatment with less
discomfort and with quicker recovery than standard surgical techniques.

Background: The NOTES team (surgeon and gastroenterologist) at Baystate has extensive
experience with animal work in developing novel techniques with commercially available
products. While we have not ever performed a cystgastrostomy on an animal, there is no
known animal model to simulate this pathologic condition. We have, however, operated the
flexible gastrointestinal anastomotic stapler translumenally in an animal model in order to
prepare for this procedure. The surgeon on the team has performed human stapled
cystgastrostomies before, via both open and laparoscopic approaches. A pilot case has
recently been done performed and the patient continues to do well.

Study Design: There will be a total of 10 patients undergoing this experimental surgical
procedure once meeting all entry criteria and subsequent to obtaining informed consent.
Follow-up endoscopic examination will be conducted approximately 6 weeks following the
procedure to determine the success of the drainage of the pseudocyst. Longer term follow-up
will be determined by the patient's overall condition. These 10 patients will be compared
to a retrospective review of 10 patients to compare pseudocyst size, degree of pain and
hospital length of stay. The degree of pain will be assessed using the Wong-Baker Pain
Scale. The retrospective series will be a matched cohort based on size of the pseudocyst
and age and comorbidities of the patient.

Safety Monitoring: Due to the novelty of the procedure, safety information will be
monitored on a continuous basis. Should there be any untoward results, the study may be
terminated prematurely, or temporarily suspended while we assess the events. In the event
of any serious adverse event or outcome, the IRB will be notified immediately.

Risks and Benefits: The anticipated risks associated with this type of surgery include:

Bleeding, infection, need for open surgery, pancreatic leak, gastric leak, inadequate
drainage of the pseudocyst. A risk specific to the NOTES approach includes trauma to
oropharynx resulting in bleeding or infection.

The anticipated benefits include a decrease in the amount of pain experienced with the
drainage of the pancreatic pseudocyst, as well as an anticipated decreased length of
hospital stay.

Statistics: A comparison of the means will be performed using both the numerical values
from the Pain Scale, the largest diameter of the pseudocyst, and the hospital length of
stay.

Data Storage: The data collected will be kept in a locked filing cabinet in the primary
investigator's office. Only the PI will have access to this file.

Enrollment Inclusion Criteria:

1. Adult (over 18 years old) patients who are able to provide informed consent for this
surgical procedure

2. Patients scheduled to undergo non-emergent surgical treatment removal of pancreatic
pseudocyst

Enrollment Exclusion Criteria:

1. Inability to provide informed consent

2. Patients who, in the opinion of the investigator, would not be appropriate for
enrollment into this experimental research project

3. Patients who are deemed to be unstable from a medical standpoint to undergo pancreatic
surgery

4. Pregnancy

It is anticipated that there will be more similar type of "natural orifice" type surgeries
in the future for a variety of procedures and a multitude of reasons (no incision, less
pain, and less time in the hospital). This surgery is the first of its kind for the
drainage of pancreatic pseudocysts.


Inclusion Criteria:



1. Adult (over 18 years old) patients who are able to provide informed consent for this
surgical procedure

2. Patients scheduled to undergo non-emergent surgical treatment removal of pancreatic
pseudocyst

Exclusion Criteria:

1. Inability to provide informed consent

2. Patients who, in the opinion of the investigator, would not be appropriate for
enrollment into this experimental research project

3. Patients who are deemed to be unstable from a medical standpoint to undergo
pancreatic surgery

4. Pregnancy

Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

Mortality Morbidity Pain

Outcome Time Frame:

One year

Safety Issue:

Yes

Principal Investigator

John R Romanelli, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Baystate Medical Center

Authority:

United States: Institutional Review Board

Study ID:

07-164

NCT ID:

NCT00541593

Start Date:

September 2007

Completion Date:

September 2010

Related Keywords:

  • Pancreatic Pseudocyst
  • Pancreatic pseudocyst
  • NOTES
  • Pancreatic Pseudocyst

Name

Location

Baystate Medical CenterSpringfield, Massachusetts  01199